Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Denton

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Arthritis Care & Research|June 18, 2023
Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus MeetingsIvan Foeldvari, Kathryn S Torok, Jordi Anton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedemaRobert Knobler, Marija Geroldinger-Simić, Alexander Kreuter, et al.
The Journal of Rheumatology|June 17, 2010
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR)Behrooz Z Alizadeh, Jasper Broen, Blanca Rueda, et al.
Arthritis Research & Therapy|December 29, 2012
KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factorLara Bossini-Castillo, Carmen P Simeon, Lorenzo Beretta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2014
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locusElena López-Isac, Lara Bossini-Castillo, Sandra G Guerra, et al.
American Journal of Hematology|November 5, 2025
Hospital Variations in Time-To-Crisis-Resolution Among Children and Adolescents With Sickle Cell DiseaseChris A Rees, Dunia Hatabah, Rawan Korman, et al.
Plos One|February 2, 2013
The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosisF David Carmona, Jose-Ezequiel Martin, Lorenzo Beretta, et al.
Arthritis Research & Therapy|January 10, 2014
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibilityElena López-Isac, Lara Bossini-Castillo, Carmen P Simeon, et al.
Rheumatology (Oxford, England)|May 13, 2017
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR groupVeronika K Jaeger, Oliver Distler, Britta Maurer, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
Arthritis Care & Research|June 18, 2023
Proposed Response Parameters for Twelve-Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus MeetingsIvan Foeldvari, Kathryn S Torok, Jordi Anton, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxoedema and scleroedemaRobert Knobler, Marija Geroldinger-Simić, Alexander Kreuter, et al.
The Journal of Rheumatology|June 17, 2010
Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR)Behrooz Z Alizadeh, Jasper Broen, Blanca Rueda, et al.
Arthritis Research & Therapy|December 29, 2012
KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factorLara Bossini-Castillo, Carmen P Simeon, Lorenzo Beretta, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 10, 2014
Identification of IL12RB1 as a novel systemic sclerosis susceptibility locusElena López-Isac, Lara Bossini-Castillo, Sandra G Guerra, et al.
American Journal of Hematology|November 5, 2025
Hospital Variations in Time-To-Crisis-Resolution Among Children and Adolescents With Sickle Cell DiseaseChris A Rees, Dunia Hatabah, Rawan Korman, et al.
Plos One|February 2, 2013
The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosisF David Carmona, Jose-Ezequiel Martin, Lorenzo Beretta, et al.
Arthritis Research & Therapy|January 10, 2014
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibilityElena López-Isac, Lara Bossini-Castillo, Carmen P Simeon, et al.
Rheumatology (Oxford, England)|May 13, 2017
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR groupVeronika K Jaeger, Oliver Distler, Britta Maurer, et al.
Pageof 6